Skip to content
10-Q

Quarterly Report

COLUCID PHARMACEUTICALS, INC.

0001564590-16-023823

← back to feed
Filed
Aug 10, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 10, 2016 15.33M sh
Cash And Equivalents Q2 2016 · Jun 30, 2016 $13.81M
Cash And Equivalents Q2 2016 · Dec 31, 2015 $27.98M
Cash And Equivalents restated Q2 2016 · Jun 30, 2015 $79.66M
Cash And Equivalents restated Q2 2016 · Dec 31, 2014 $204K
Stockholders Equity Q2 2016 · Jun 30, 2016 $31.05M
Stockholders Equity Q2 2016 · Dec 31, 2015 $58.41M
Current Liabilities Q2 2016 · Jun 30, 2016 $10.26M
Current Liabilities Q2 2016 · Dec 31, 2015 $5.43M
Total Liabilities Q2 2016 · Jun 30, 2016 $11.76M
Total Liabilities Q2 2016 · Dec 31, 2015 $6.93M
Current Assets Q2 2016 · Jun 30, 2016 $41.27M
Current Assets Q2 2016 · Dec 31, 2015 $65.32M
Total Assets Q2 2016 · Jun 30, 2016 $42.81M
Total Assets Q2 2016 · Dec 31, 2015 $65.34M
Sga Expense Q2 2016 · Jun 30, 2016 $1.96M
Sga Expense Q2 2016 · Jun 30, 2016 $4.28M
Sga Expense restated Q2 2016 · Jun 30, 2015 $1.98M
Sga Expense restated Q2 2016 · Jun 30, 2015 $2.83M
Rd Expense Q2 2016 · Jun 30, 2016 $14.38M
Rd Expense Q2 2016 · Jun 30, 2016 $25.2M
Rd Expense restated Q2 2016 · Jun 30, 2015 $5.8M
Rd Expense restated Q2 2016 · Jun 30, 2015 $7.76M
Net Income Q2 2016 · Jun 30, 2016 −$16.28M
Net Income Q2 2016 · Jun 30, 2016 −$29.34M
Net Income restated Q2 2016 · Jun 30, 2015 −$7.76M
Net Income restated Q2 2016 · Jun 30, 2015 −$10.56M
Operating Income Q2 2016 · Jun 30, 2016 −$16.34M
Operating Income Q2 2016 · Jun 30, 2016 −$29.48M
Operating Income restated Q2 2016 · Jun 30, 2015 −$7.78M
Operating Income restated Q2 2016 · Jun 30, 2015 −$10.59M